NCT04020185 2024-12-11Safety and Efficacy Study of IMSA101 in Refractory MalignanciesImmuneSensor Therapeutics Inc.Phase 1/2 Completed40 enrolled 16 charts
NCT01040026 2023-04-04Expanded Natural Killer (NK) Cells for Multiple Myeloma StudyUniversity Hospital, Basel, SwitzerlandPhase 1/2 Completed10 enrolled